The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Recurrent gain-of-function USP8 mutations in Cushing's disease
Open accessAbstract
Cushing's disease, also known as adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas (PAs) that cause excess cortisol production, accounts for up to 85% of corticotrophin-dependent Cushing's syndrome cases. However, the genetic alterations in this disease are unclear. Here, we performed whole-exome sequencing of DNA derived from 12 ACTH-secreting PAs and matched blood samples, which revealed three types of somatic mutations in a candidate gene, USP8 (encoding ubiquitin-specific protease 8), exclusively in exon 14 in 8 of 12 ACTH-secreting PAs. We further evaluated somatic USP8 mutations in additional 258 PAs by Sanger sequencing. Targeted sequencing further identified a total of 17 types of USP8 variants in 67 of 108 ACTH-secreting PAs (62.04%). However, none of these mutations was detected in other types of PAs (n = 150). These mutations aggregate within the 14-3-3 binding motif of USP8 and disrupt the interaction between USP8 and 14-3-3 protein, resulting in an elevated capacity to protect EGFR from lysosomal degradation. Accordingly, PAs with mutated USP8 display a higher incidence of EGFR expression, elevated EGFR protein abundance and mRNA expression levels of POMC, which encodes the precursor of ACTH. PAs with mutated USP8 are significantly smaller in size and have higher ACTH production than wild-type PAs. In surgically resected primary USP8-mutated tumor cells, USP8 knockdown or blocking EGFR effectively attenuates ACTH secretion. Taken together, somatic gain-of-function USP8 mutations are common and contribute to ACTH overproduction in Cushing's disease. Inhibition of USP8 or EGFR is promising for treating USP8-mutated corticotrophin adenoma. Our study highlights the potentially functional mutated gene in Cushing's disease and provides insights into the therapeutics of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome
Weinstein, L. S., Shenker, A., Gejman, P. V., Merino, M. J., Friedman, E., & Spiegel, A. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252403 · Cited by 1,691
The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity
Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H., Gamblin, S. J., Smerdon, S. J., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)80487-0 · Cited by 1,604
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Pituitary Adenomas with Invasion of the Cavernous Sinus Space
Knosp, E., Steiner, E., Kitz, K., & Matula, C. (1993) · Neurosurgery · doi:10.1097/00006123-199310000-00008 · Cited by 1,208
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Chu, I. M., Hengst, L., & Slingerland, J. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2347 · Cited by 990
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Mutations in the deubiquitinase gene USP8 cause Cushing's disease
Reincke, M., Sbiera, S., Hayakawa, A., Theodoropoulou, M., Osswald, A., Beuschlein, F., Meitinger, T., Mizuno-Yamasaki, E., Kawaguchi, K., Saeki, Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3166 · Cited by 599
Clonal Origin of Pituitary Adenomas*
HERMAN, V., FAGIN, J., GONSKY, R., KOVACS, K., & MELMED, S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1427 · Cited by 560
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
Vallar, L., Spada, A., & Giannattasio, G. (1987) · Nature · doi:10.1038/330566a0 · Cited by 514
CANDIA, S. D. (1951) · PubMed · Cited by 365
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Fukuoka, H., Cooper, O., Ben-Shlomo, A., Mamelak, A., Ren, S.-G., Bruyette, D., & Melmed, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60417 · Cited by 254
Mizuno, E., Iura, T., Mukai, A., Yoshimori, T., Kitamura, N., & Komada, M. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0560 · Cited by 248
Bilodeau, S., Vallette-Kasic, S., Gauthier, Y., Figarella-Branger, D., Brue, T., Berthelet, F., Lacroix, A., Batista, D., Stratakis, C., Hanson, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1444606 · Cited by 242
Syndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235
Stratakis, C., Tichomirowa, M., Boikos, S., Azevedo, M., Lodish, M., Martari, M., Verma, S., Daly, A., Raygada, M., Keil, M., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01406.x · Cited by 210
Niendorf, S., Oksche, A., Kisser, A., Löhler, J., Prinz, M., Schorle, H., Feller, S., Lewitzky, M., Horak, I., & Knobeloch, K.-P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01566-06 · Cited by 207
Lidhar, K. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3823 · Cited by 196
Cazabat, L., Bouligand, J., Salenave, S., Bernier, M., Gaillard, S., Parker, F., Young, J., Guiochon-Mantel, A., & Chanson, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2291 · Cited by 185
Karl, M., Lamberts, S. W. J., Koper, J. W., Katz, D. A., Huizenga, N. A. T. M., Kino, T., Haddad, B. R., Hughes, M. R., & Chrousos, G. P. (1996) · PubMed · Cited by 180
UBPY: a growth‐regulated human ubiquitin isopeptidase
Naviglio, S., Matteucci, C., Matoskova, B., Nagase, T., Nomura, N., Di Fiore, P. P., & Draetta, G. F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3241 · Cited by 174
AIP Mutation in Pituitary Adenomas in the 18th Century and Today
Chahal, H. S., Stals, K., Unterländer, M., Balding, D. J., Thomas, M. G., Kumar, A. V., Besser, G. M., Atkinson, A. B., Morrison, P. J., Howlett, T. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008020 · Cited by 163
USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer
Byun, S., Lee, S., Lee, J., Jeong, C., Farrand, L., Lim, S., Reddy, K., Kim, J. Y., Lee, M., Lee, H. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3696 · Cited by 152
Xia, R., Jia, H., Fan, J., Liu, Y., & Jia, J. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001238 · Cited by 131
Self-citationBerlin, I., Schwartz, H., & Nash, P. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016287 · Cited by 121
Theodoropoulou, M., Arzberger, T., Grübler, Y., Jaffrain‐Rea, M., Schlegel, J., Schaaf, L., Petrangeli, E., Losa, M., Stalla, G. K., & Pagotto, U. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05616 · Cited by 105
Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease
Biller, B. M. K., Alexander, J. M., Zervas, N. T., Hedley‐Whyte, E. T., Arnold, A., & Klibanski, A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.5.1358909 · Cited by 100
Mizuno, E., Kitamura, N., & Komada, M. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.028 · Cited by 98
Sahakitrungruang, T., Srichomthong, C., Pornkunwilai, S., Amornfa, J., Shuangshoti, S., Kulawonganunchai, S., Suphapeetiporn, K., & Shotelersuk, V. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1016 · Cited by 78
Managing Cushing’s disease: the state of the art
Colao, A., Boscaro, M., Ferone, D., & Casanueva, F. F. (2014) · Endocrine · doi:10.1007/s12020-013-0129-2 · Cited by 71
P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease
Kawashima, S., Usui, T., Sano, T., Iogawa, H., Hagiwara, H., Tamanaha, T., Tagami, T., Naruse, M., Hojo, M., Takahashi, J. A., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03404.x · Cited by 56
Vila, G., Theodoropoulou, M., Stalla, J., Tonn, J. C., Losa, M., Renner, U., Stalla, G. K., & Páez-Pereda, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1014 · Cited by 50
Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency
Drouin, J., Bilodeau, S., & Vallette-Kasic, S. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00877.x · Cited by 46
Menis, E. D., Roncaroli, F., Calvari, V., Chiarini, V., Pauletto, P., Camerino, G., & Cremonini, N. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01958 · Cited by 22
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940
Breaking the chains: deubiquitylating enzyme specificity begets function
Clague, M. J., Urbé, S., & Komander, D. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0099-1 · Cited by 832
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
Lopes, M. B. S. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1769-8 · Cited by 548
Metadata
- Authors
- Ma, Z.-Y., Song, Z.-J., Chen, J.-H., Wang, Y.-F., Li, S.-Q., Zhou, L.-F., Mao, Y., Li, Y.-M., Hu, R.-G., Zhang, Z.-Y., Ye, H.-Y., Shen, M., Shou, X.-F., Li, Z.-Q., Peng, H., Wang, Q.-Z., Zhou, D.-Z., Qin, X.-L., Ji, J., Zheng, J., Chen, H., Wang, Y., Geng, D.-Y., Tang, W.-J., Fu, C.-W., Shi, Z.-F., Zhang, Y.-C., Ye, Z., He, W.-Q., Zhang, Q.-L., Tang, Q.-S., Xie, R., Shen, J.-W., Wen, Z.-J., Zhou, J., Wang, T., Huang, S., Qiu, H.-J., Qiao, N.-D., Zhang, Y., Pan, L., Bao, W.-M., Liu, Y.-C., Huang, C.-X., Shi, Y.-Y., & Zhao, Y.
- Venue
- Cell Research
- Published
- 2015-02-13
- Volume
- 25
- Issue
- 3
- Pages
- 306-317
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W2026098321
- Cited by
- 368
- References
- 36
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.